1. Immunoadjuvants for cancer immunotherapy
2. Nanotechnology as an emerging option in cancer immunotherapy
3. Different administration routes for nanovectors in cancer
immunotherapy
4. Two-dimensional materialbased nanomedicines for cancer
immunotherapy
5. Hydrogel-based nanomedicines for cancer immunotherapy
6. Exosomes-based nanomedicines for cancer immunotherapy
7. Lipid-based nanomedicines for cancer immunotherapy
8. Inorganic nanoparticle-based nanomedicines for cancer
immunotherapy
9. Liposome-based nanomedicines for cancer immunotherapy
10. Biomembrane-based nanoparticles for cancer immunotherapy
11. Dendrimer-based nanomedicines for cancer immunotherapy
12. Magnetic nanocarriers for cancer immunotherapy
13. Inhaled delivery of immunotherapy for treatment of lung
cancer
14. Nano-based vaccination and their administration routes in
cancer immunotherapy
15. Current status, challenges, and future perspective of
nanomedicine-based cancer immunotherapy
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award, most prestigious “SERB-Ramanujan Fellowship Award. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
|
Ask a Question About this Product More... |
|
